BOLTON SECURITIES CORPORATION’s Globus Medical GMED Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$277K Buy
3,692
+16
+0.4% +$1.27K 0.01% 781
2026
Q2
$290K Buy
3,676
+1,126
+44% +$95.7K 0.01% 775
2026
Q1
$220K Buy
+2,550
New +$229K 0.01% 785
2025
Q3
$4.87K Buy
+85
New +$4.9K ﹤0.01% 1710
2025
Q1
$69.5K Buy
+949
New +$78.4K ﹤0.01% 957

Other funds holding GMED

BOLTON SECURITIES CORPORATION's GMED Position: Q3 2026 in Review

BOLTON SECURITIES CORPORATION increased its Globus Medical (GMED) stake by 0.44% in Q3 2026, buying an estimated $1.27K and bringing the position to 3,692 shares worth $277K. The position accounts for 0.01% of the portfolio, ranked #781.

BOLTON SECURITIES CORPORATION first reported a position in GMED in Q1 2025 and has held it in 5 quarters since. The position peaked at $290K in Q2 2026. 412 funds tracked by Wall St. Rank hold GMED as of Q3 2026.

  • BOLTON SECURITIES CORPORATION held 3,692 shares of Globus Medical worth $277K as of Q3 2026.
  • BOLTON SECURITIES CORPORATION bought 16 Globus Medical shares in Q3 2026, an estimated $1.27K.
  • Globus Medical made up 0.01% of BOLTON SECURITIES CORPORATION's portfolio in Q3 2026, its #781 holding.
  • BOLTON SECURITIES CORPORATION first reported a position in Globus Medical in Q1 2025 and has held it in 5 quarters since.
  • BOLTON SECURITIES CORPORATION's Globus Medical position peaked at $290K in Q2 2026.
  • 412 funds tracked by Wall St. Rank held Globus Medical as of Q3 2026.

Based on BOLTON SECURITIES CORPORATION's 13F filing for Q3 2026, filed 12 Nov 2026.